Picard Medical, Inc.
PMI
$0.46
-$0.02-3.93%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.50% | 8.81% | 1.36% | -45.90% | -12.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.50% | 8.81% | 1.36% | -45.90% | -12.93% |
| Cost of Revenue | 14.23% | -8.61% | -0.42% | -37.77% | -40.70% |
| Gross Profit | -82.14% | 64.75% | 7.51% | 3.26% | 95.61% |
| SG&A Expenses | -2.11% | -12.71% | -5.58% | -1.08% | -6.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.52% | -9.00% | -0.67% | -8.03% | -11.89% |
| Operating Income | 3.32% | 13.86% | 1.27% | -7.03% | 11.55% |
| Income Before Tax | -27.99% | -73.15% | -78.62% | -73.92% | -35.32% |
| Income Tax Expenses | 333.33% | 900.00% | 900.00% | 900.00% | -650.00% |
| Earnings from Continuing Operations | -28.25% | -73.26% | -78.75% | -74.06% | -35.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.25% | -73.26% | -78.75% | -74.06% | -35.24% |
| EBIT | 3.32% | 13.86% | 1.27% | -7.03% | 11.55% |
| EBITDA | 2.91% | 13.11% | -0.51% | -10.64% | 9.59% |
| EPS Basic | 42.44% | -8.82% | -57.12% | -64.53% | -31.85% |
| Normalized Basic EPS | 35.14% | -20.52% | -74.18% | -73.84% | -35.32% |
| EPS Diluted | 42.44% | -8.82% | -57.12% | -64.53% | -31.85% |
| Normalized Diluted EPS | 35.14% | -20.52% | -74.18% | -73.84% | -35.32% |
| Average Basic Shares Outstanding | 356.13% | 149.19% | 2.82% | 0.06% | 0.00% |
| Average Diluted Shares Outstanding | 356.13% | 149.19% | 2.82% | 0.06% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |